ClinicalTrialsFinder

Uterine Serous Carcinoma Clinical Trials in Bordeaux, Aquitaine

1 recruitingBordeaux, Aquitaine, France

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

Non-small Cell Lung Cancer (NSCLC)High-grade Serous Ovarian Carcinoma (HGSOC)Uterine Serous Carcinoma (USC)
Bristol-Myers Squibb240 enrolled17 locationsNCT06476808